Skip to content

Sharplink, Inc. SBET Deferred Tax Assets Capitalized Research And Development

Deferred Tax Assets Capitalized Research And Development at other companies

Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$6.24M+144%
Minerals Technologies logo
Minerals TechnologiesMTX
$12.6M+14.5%
Corvex
 logo
Corvex MOVE
$5.16M-27.5%
Nuvation Bio logo
Nuvation BioNUVB
$78.79M-19.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$233.49M-27.8%
PepsiCo logo
PepsiCoPEP
$134M-47.7%

Other financials

Income statement

See full
Revenue$12.1M+1,525%
Gross profit$209.1K-25.4%
Operating income-$684.6M-73,829%
Net income-$685.6M-70,214%
EPS (diluted)-$3.25-76.6%

Balance sheet

See full
Cash & equivalents$16.9M+3,275%
Total debt$6.5M+213%
Total equity$1.7B+83,286%
Total assets$1.7B+62,686%

Cash flow

See full
Operating cash flow-$10.6M-1,971%
CapEx$3.7K+1,223%
Free cash flow-$9.1M-620%

Valuation

See full
Market cap$1B+61.1%
P/S25.5×-156×

Profitability

See full
Gross margin35.8%
Operating margin-3,600.5%-3,725pp
Net margin-3,604.6%-3,675pp
FCF margin-623%

Returns & leverage

See full
Return on equity-163.1%+447pp
Debt / equity0.7×
Current ratio3.3×0.0×

Where this comes from

Reported directly by Sharplink, Inc. in its filing.

Tagged under the XBRL concept SBET:DeferredTaxAssetsCapitalizedResearchAndDevelopment.

The official record: Sharplink, Inc. ’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sharplink, Inc. 's deferred tax assets capitalized research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sharplink, Inc. 's deferred tax assets capitalized research and development?
Sharplink, Inc. (SBET) reported deferred tax assets capitalized research and development of $158K in Q4 2024.
What does deferred tax assets capitalized research and development mean?
This metric captures the deferred tax assets created by the capitalization of research and development costs for tax purposes, which differ from the expense recognition in financial reporting. It represents future tax deductions that will reduce the company's cash tax payments in subsequent periods. Monitoring this helps investors assess the tax efficiency of the company's R&D investment strategy.